A SAFE (Simple Agreement for Future Equity) is a convertible instrument widely used in pre-seed and seed fundraising. Invented by Y Combinator in 2013, it allows investors to provide capital to a startup that converts into equity at a future priced round, without requiring an immediate valuation negotiation. SAFEs have become the default early-stage fundraising instrument in US Silicon Valley deals, with adoption spreading globally over the past decade.

SAFEs typically include a valuation cap (the maximum company valuation at which the SAFE converts) and/or a discount rate (a percentage reduction on the price per share at the next priced round, rewarding early investors for their risk). A SAFE with a $6M cap and a 20% discount gives the investor equity at the lower of the two terms when the next priced round closes. If the next round prices at $20M, the investor converts at the $6M cap; if it prices at $4M, the investor takes the 20% discount on the $4M (effectively $3.2M).

SAFEs are founder-friendly compared to convertible notes because they have no interest rate, no maturity date, and no debt obligations. They are simple, fast, and cheap to execute (Y Combinator publishes the standard documents free), a key reason they've become the default instrument for early-stage rounds. A founder can close a SAFE with an angel investor in a single conversation; the same conversation on a priced round would require several weeks of legal work and $20K–$40K in fees.

Y Combinator's original 2013 SAFE was a pre-money SAFE — the cap was the maximum valuation before the new round, meaning the SAFE issuance affected the post-money valuation as more SAFEs accumulated. YC released the post-money SAFE in 2018, which fixes the dilution math regardless of subsequent SAFE issuance. Post-money SAFEs are now the dominant form because they're easier to model — investors know their exact ownership percentage from the moment they sign.

From an investor's perspective, the key risk with SAFEs is dilution uncertainty in pre-money structures and conversion delay risk: if the company never raises a priced round, the SAFE may never convert. Sophisticated investors negotiate a most-favored-nation (MFN) clause, which lets them re-paper their SAFE if a later investor receives better terms. Investors also typically ask for pro-rata rights, which let them participate in future rounds at their proportional ownership level.

Founders should track total SAFE dilution carefully. Stacking multiple SAFEs at different caps can dilute the founders 25–40% by the time a priced Series A closes, which surprises founders who modeled only the first SAFE. The standard early-stage cap table tool (Pulley, Carta, Capdesk) will project this dilution under different round-size and valuation scenarios; running this analysis before signing each SAFE prevents post-Series-A regret.